Sugar Control P 1mg/500mg/15mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugar Control P 1mg/500mg/15mg Tablet
DiaBeta Plus (1mg/500mg/15mg) tablets combine ingredients to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Always follow your physician's prescribed dosage and regimen for DiaBeta Plus. Take with food to minimize digestive discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in that case, omit the missed dose and resume your usual schedule. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before starting treatment. Pregnant or nursing individuals require medical consultation prior to use. Kidney function tests are conducted before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Uses of Sugar Control P 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Sugar Control P 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugar Control P 1mg/500mg/15mg Tablet with a meal.
Common Side effects of Sugar Control P 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugar Control P 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugar Control P 1mg/500mg/15mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Sugar Control P 1mg/500mg/15mg Tablet works:
SugarControl P (1mg/500mg/15mg) tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Sugar Control P 1mg/500mg/15mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sugar Control P 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible hazards before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sugar Control P 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use the 1mg/500mg/15mg Sugar Control P tablet cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Sugar Control P 1mg/500mg/15mg tablets, as dosage modification may be necessary. Consult a physician for guidance. This medication is contraindicated in individuals with severe liver disease.
What if you forget to take Sugar Control P 1mg/500mg/15mg Tablet :
Should you forget to take a Sugar Control P 1mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugar Control P 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently